Followers | 294 |
Posts | 40645 |
Boards Moderated | 10 |
Alias Born | 08/30/2001 |
Thursday, May 13, 2010 5:45:17 PM
STAMFORD, Conn., May 13 /PRNewswire/ --
Zargis Medical Corp., a majority-owned subsidiary of Speedus Corp. (Nasdaq: SPDE), today announced that it has been selected by the U.S. Army's Telemedicine & Advanced Technology Research Center (TATRC) to present the Company's latest technologies at the TATRC exhibit during this year's American Telemedicine Association Conference (ATA), which takes place May 16-18 at the Henry B. Gonzalez Convention Center in San Antonio, TX.
"We are honored to have been selected by TATRC to present our industry leading medical devices at this premier conference," stated Zargis CEO, John Kallassy. "This presentation represents the first major marketing event for Zargis' new, award winning tele-auscultation platforms."
In addition to participating with TATRC at this conference, Zargis will also be demonstrating its newly introduced ZargisTelemed™ platform, which allows recordings from electronic stethoscopes to be easily transmitted between healthcare professionals via the Internet.
For more information about Zargis' tele-auscultation tools or to arrange a demonstration call 609-488-4608 begin_of_the_skype_highlighting 609-488-4608 end_of_the_skype_highlighting.
PROTECT YOUR ASS-ets!!
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM